Soluble urokinase plasminogen activator surface receptor as a prognostic biomarker in heart failure

13 May 2024 (13:00 - 14:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Amra Jujic

Lund University, Malmo (Sweden)

7 More presentations in this session

Presentation thumbnail

Identifying predictors of risk stratification in hospitalized heart failure patients

Doctor J. Cizek (Prague, CZ)

Abstract Slides Video

Presentation thumbnail

Incidence and predictors of worsening heart failure.

Doctor J. Bonilla Palomas (Ubeda, ES)

Abstract Slides Video

Presentation thumbnail

Incidence and predictors of mortality and hospital readmissions in a contemporary cohort of patients with heart failure.

Doctor J. Bonilla Palomas (Ubeda, ES)

Abstract Slides Video

Presentation thumbnail

Comparison of clinical characteristics and survival between ischemic and non-ischemic patients heart failure patients with reduced ejection fraction: an observational study

Doctor M. Kose (Izmir, TR)

Abstract Slides Video

Presentation thumbnail

Baseline characteristics and one year outcome of patients in CABG PREFERS (coronary artery bypass graft preserved and reduced ejection fraction epidemiological regional study)

Doctor U. Lofstrom (Stockholm, SE)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - epidemiology, prognosis, outcome 7

The Event

Event poster

Heart Failure 2024

13 May 2024 13:00 CET

You may be interested in

Congress Presentation

Soluble urokinase-type plasminogen activator surface receptor is associated with kidney disease in heart failure patients

Congress Session

Refining diagnosis in heart failure

Congress Session

Biomarkers definning pathophysiology and prognosis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources